JPMorgan Resumes Pfizer (PFE) at Overweight
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $25.08 -0.52%
Rating Summary:
15 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
15 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
JPMorgan resumed coverage on Pfizer (NYSE: PFE) with an Overweight rating and a price target of $38.00.
For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.
Shares of Pfizer closed at $32.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Capital Starts Flutter Entertainment (FLUT) at Hold
- H.C. Wainwright Starts Faeth Therapeutics (FTH) at Buy
- JPMorgan Starts Hyundai Mobis Co Ltd. (012330:KS) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
